{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:45:03Z","timestamp":1765547103225,"version":"3.40.5"},"reference-count":58,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>The prevalence of hypothyroidism increases along with aging, resulting in\none of the most common comorbidities among patients over 75 years. The leading causes of hypothyroidism\nin older adults are iatrogenic, Hashimoto's thyroiditis, and medications. The narrative review\naimed to discuss the clinical characteristics of hypothyroidism in older adults and the impact of hormonal\nreplacement therapy on survival rates. Thyroid function declines over time due to physiological\nchanges in the thyroid stimulating hormone signaling, iodine absorption and metabolism, thyroid hormone\nmetabolism, and activity at peripheral sites. A serum TSH value over the upper limit of the normal\nreference range is not necessarily attributable to hypothyroidism. However, an appropriate diagnostic\nwork-up is required to rule out true hypothyroidism and discriminate the etiology (i.e., thyroid\nautoimmune diseases, iodine deficiency, drug-induced hypothyroidism). Levothyroxine treatment\nshould be considered in cases of overt hypothyroidism. A complete risk-to-benefit assessment, particularly\nconsidering the overall health status, life expectancy, cognitive function, mood, and cardiovascular\nand neurological background, should be considered before treating subclinical hypothyroidism\nwith more potential benefits in patients under 75 years old. Levothyroxine formulations facilitating\nhormone absorption and increasing compliance to long-term treatment should be preferred. TSH\ntarget should usually be set over 3 mIU\/ml. Defining optimal diagnostic approaches and targeted therapeutic\nstrategies should be considered in the personalized management of aged patients with hypothyroidism.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Thyroid function declines over time due to physiological changes in the thyroid stimulating hormone signaling, iodine absorption and metabolism, thyroid hormone metabolism, and activity at peripheral sites. A serum TSH value over the upper limit of the normal reference range is not necessarily attributable to hypothyroidism. However, an appropriate diagnostic work-up is required to rule out true hypothyroidism and discriminate the etiology (i.e., thyroid autoimmune diseases, iodine deficiency, drug-induced hypothyroidism). Levothyroxine treatment should be considered in cases of overt hypothyroidism. A complete risk-to-benefit assessment, particularly considering the overall health status, life expectancy, cognitive function, mood, and cardiovascular and neurological background, should be considered before treating subclinical hypothyroidism with more potential benefits in patients under 75 years old. Levothyroxine formulations facilitating hormone absorption and increasing compliance to long-term treatment should be preferred. TSH target should usually be set over 3 mIU\/ml.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530323666230828110153","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:37:12Z","timestamp":1693294632000},"page":"879-884","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hypothyroidism in Older Adults: A Narrative Review"],"prefix":"10.2174","volume":"24","author":[{"given":"Vincenzo","family":"Fiore","sequence":"first","affiliation":[{"name":"UOSD Diabetologia \u2013 Endocrinologia, ASL RM5, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Barucca","sequence":"additional","affiliation":[{"name":"UOSD Diabetologia \u2013 Endocrinologia, ASL RM5, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Barraco","sequence":"additional","affiliation":[{"name":"UOSD Diabetologia \u2013 Endocrinologia, ASL RM5, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Triggiani","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Carbotta","sequence":"additional","affiliation":[{"name":"UOSD Diabetologia \u2013 Endocrinologia, ASL RM5, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7073-1795","authenticated-orcid":true,"given":"Vito Angelo","family":"Giagulli","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3221-6562","authenticated-orcid":true,"given":"Giuseppina","family":"Piazzolla","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6521-8578","authenticated-orcid":true,"given":"Giuseppe","family":"Lisco","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, University\nof Bari A. Moro, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6308-0528","authenticated-orcid":true,"given":"Vincenzo","family":"Triggiani","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrendo.2013.30","volume":"9","author":"Boelaert K.","year":"2013","unstructured":"Boelaert K.; Thyroid dysfunction in the elderly. Nat Rev Endocrinol  2013,9(4),194-204","journal-title":"Nat Rev Endocrinol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","volume":"29","author":"Biondi B.","year":"2008","unstructured":"Biondi B.; Cooper D.S.; The clinical significance of subclinical thyroid dysfunction. Endocr Rev  2008,29(1),76-131","journal-title":"Endocr Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/nu12061669","volume":"12","author":"Lisco G.","year":"2020","unstructured":"Lisco G.; De Tullio A.; Giagulli V.A.; De Pergola G.; Triggiani V.; Interference on iodine uptake and human thyroid function by perchlorate-contaminated water and food. Nutrients  2020,12(6),1669","journal-title":"Nutrients"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/nu15041004","volume":"15","author":"Lisco G.","year":"2023","unstructured":"Lisco G.; De Tullio A.; Triggiani D.; Zupo R.; Giagulli V.A.; De Pergola G.; Piazzolla G.; Guastamacchia E.; Sabb\u00e0 C.; Triggiani V.; Iodine deficiency and iodine prophylaxis: An overview and update. Nutrients  2023,15(4),1004","journal-title":"Nutrients"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1365-2265.1997.2271040.x","volume":"47","author":"Szabolcs I.","year":"1997","unstructured":"Szabolcs I.; Podoba J.; Feldkamp J.; Doh\u00e1n O.; Farkas I.; Sajg\u00f3 M.; Tak\u00e1ts K.I.; G\u00f3th M.; Kov\u00e1cs L.; Kressinszky K.; Hnilica P.; Szil\u00e1gyi G.; Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clin Endocrinol  1997,47(1),87-92","journal-title":"Clin Endocrinol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fendo.2014.00153","volume":"5","author":"Tognini S.","year":"2014","unstructured":"Tognini S.; Pasqualetti G.; Calsolaro V.; Polini A.; Caraccio N.; Monzani F.; Cardiovascular risk and quality of life in elderly people with mild thyroid hormone deficiency. Front Endocrinol  2014,5,153","journal-title":"Front Endocrinol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/1872214808666140723111533","volume":"8","author":"Tognini S.","year":"2014","unstructured":"Tognini S.; Pasqualetti G.; Calsolaro V.; Polini A.; Monzani F.; Cognitive function and quality of life in mild thyroid hormone deficiency. Recent Pat Endocr Metab Immune Drug Discov  2014,8(2),124-134","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/antiox10091442","volume":"10","author":"Kochman J.","year":"2021","unstructured":"Kochman J.; Jakubczyk K.; Bargiel P.; Janda-Milczarek K.; The influence of oxidative stress on thyroid diseases. Antioxidants  2021,10(9),1442","journal-title":"Antioxidants"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2165\/00024677-200605020-00001","volume":"5","author":"Monzani F.","year":"2006","unstructured":"Monzani F.; Dardano A.; Caraccio N.; Does treating subclinical hypothyroidism improve markers of cardiovascular risk? Treat Endocrinol  2006,5(2),65-81","journal-title":"Treat Endocrinol"},{"key":"ref=10","author":"Braverman L.E.","year":"2005","unstructured":"Braverman L.E.; Utiger R.D.;  Werner and Ingbar\u2019s, The Thyroid, a Fundamental and clinical text  2005","journal-title":"Werner and Ingbar\u2019s, The Thyroid, a Fundamental and clinical text"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1210\/jcem.77.5.8077303","volume":"77","author":"Mariotti S.","year":"1993","unstructured":"Mariotti S.; Barbesino G.; Caturegli P.; Bartalena L.; Sansoni P.; Fagnoni F.; Monti D.; Fagiolo U.; Franceschi C.; Pinchera A.; Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab  1993,77(5),1130-1134","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1210\/edrv-16-6-686","volume":"16","author":"Mariotti S.","year":"1995","unstructured":"Mariotti S.; Franceschi C.; Cossarizza A.; Pinchera N.; The aging thyroid. Endocr Rev  1995,16(6),686-715","journal-title":"Endocr Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1210\/jc.2007-1499","volume":"92","author":"Surks M.I.","year":"2007","unstructured":"Surks M.I.; Hollowell J.G.; Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: Implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab  2007,92(12),4575-4582","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jama.1979.03300030019013","volume":"242","author":"Sawin C.T.","year":"1979","unstructured":"Sawin C.T.; Chopra D.; Azizi F.; Mannix J.E.; Bacharach P.; The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA  1979,242(3),247-250","journal-title":"JAMA"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","year":"2015","unstructured":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc  2015,63(11),2227-2246","journal-title":"J Am Geriatr Soc"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1210\/jc.2012-2481","volume":"97","author":"Waring A.C.","year":"2012","unstructured":"Waring A.C.; Arnold A.M.; Newman A.B.; B\u00f9\u017ekov\u00e1 P.; Hirsch C.; Cappola A.R.; Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab  2012,97(11),3944-3950","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1210\/jc.2011-2684","volume":"97","author":"Waring A.C.","year":"2012","unstructured":"Waring A.C.; Harrison S.; Samuels M.H.; Ensrud K.E.; LeBlanc E.S.; Hoffman A.R.; Orwoll E.; Fink H.A.; Barrett-Connor E.; Bauer D.C.; Thyroid function and mortality in older men: A prospective study. J Clin Endocrinol Metab  2012,97(3),862-870","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1210\/jc.2010-0875","volume":"95","author":"Rozing M.P.","year":"2010","unstructured":"Rozing M.P.; Houwing-Duistermaat J.J.; Slagboom P.E.; Beekman M.; Fr\u00f6lich M.; de Craen A.J.M.; Westendorp R.G.J.; van Heemst D.; Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab  2010,95(11),4979-4984","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/ageing\/afq116","volume":"39","author":"Corsonello A.","year":"2010","unstructured":"Corsonello A.; Montesanto A.; Berardelli M.; De Rango F.; Dato S.; Mari V.; Mazzei B.; Lattanzio F.; Passarino G.; A cross-section analysis of FT3 age-related changes in a group of old and oldest-old subjects, including centenarians\u2019 relatives, shows that a down-regulated thyroid function has a familial component and is related to longevity. Age Ageing  2010,39(6),723-727","journal-title":"Age Ageing"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1210\/jc.2011-3020","volume":"97","author":"Bremner A.P.","year":"2012","unstructured":"Bremner A.P.; Feddema P.; Leedman P.J.; Brown S.J.; Beilby J.P.; Lim E.M.; Wilson S.G.; O\u2019Leary P.C.; Walsh J.P.; Age-related changes in thyroid function: A longitudinal study of a community-based cohort. J Clin Endocrinol Metab  2012,97(5),1554-1562","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1210\/er.2009-0011","volume":"30","author":"Zimmermann M.B.","year":"2009","unstructured":"Zimmermann M.B.; Iodine deficiency. Endocr Rev  2009,30(4),376-408","journal-title":"Endocr Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr030","volume":"99","author":"Vanderpump M.P.J.","year":"2011","unstructured":"Vanderpump M.P.J.; The epidemiology of thyroid disease. Br Med Bull  2011,99(1),39-51","journal-title":"Br Med Bull"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.23736\/S0026-4806.16.04918-1","volume":"108","author":"Vanderpump M.P.","year":"2017","unstructured":"Vanderpump M.P.; Epidemiology of iodine deficiency. Minerva Med  2017,108(2),116-123","journal-title":"Minerva Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12020-014-0441-5","volume":"49","author":"Grani G.","year":"2015","unstructured":"Grani G.; Carbotta G.; Nesca A.; D\u2019Alessandri M.; Vitale M.; Del Sordo M.; Fumarola A.; A comprehensive score to diagnose Hashimoto\u2019s thyroiditis: A proposal. Endocrine  2015,49(2),361-365","journal-title":"Endocrine"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000071713","volume":"49","author":"D\u00edez J.J.","year":"2003","unstructured":"D\u00edez J.J.; Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology  2003,49(5),316-323","journal-title":"Gerontology"},{"key":"ref=26","author":"Kim M.","year":"2000","unstructured":"Kim M.; Hypothyroidism in the Elderly. Endotext  2000","journal-title":"Endotext"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijcard.2016.12.066","volume":"230","author":"Carbotta G.","year":"2017","unstructured":"Carbotta G.; Tartaglia F.; Giuliani A.; Carbotta S.; Tromba L.; Jacomelli I.; De Anna L.; Fumarola A.; Cardiovascular risk in chronic autoimmune thyroiditis and subclinical hypothyroidism patients. A cluster analysis. Int J Cardiol  2017,230,115-119","journal-title":"Int J Cardiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1871530311313010004","volume":"13","author":"Pasqualetti G.","year":"2013","unstructured":"Pasqualetti G.; Tognini S.; Polini A.; Caraccio N.; Monzani F.; Subclinical hypothyroidism and heart failure risk in older people. Endocr Metab Immune Disord Drug Targets  2013,13(1),13-21","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","volume":"126","author":"Gencer B.","year":"2012","unstructured":"Gencer B.; Collet T.H.; Virgini V.; Bauer D.C.; Gussekloo J.; Cappola A.R.; Nanchen D.; den Elzen W.P.J.; Balmer P.; Luben R.N.; Iacoviello M.; Triggiani V.; Cornuz J.; Newman A.B.; Khaw K.T.; Jukema J.W.; Westendorp R.G.J.; Vittinghoff E.; Aujesky D.; Rodondi N.; Subclinical thyroid dysfunction and the risk of heart failure events: An individual participant data analysis from 6 prospective cohorts. Circulation  2012,126(9),1040-1049","journal-title":"Circulation"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1210\/jc.2006-1075","volume":"91","author":"Taddei S.","year":"2006","unstructured":"Taddei S.; Caraccio N.; Virdis A.; Dardano A.; Versari D.; Ghiadoni L.; Ferrannini E.; Salvetti A.; Monzani F.; Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab  2006,91(12),5076-5082","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1210\/jc.2003-030039","volume":"88","author":"Taddei S.","year":"2003","unstructured":"Taddei S.; Caraccio N.; Virdis A.; Dardano A.; Versari D.; Ghiadoni L.; Salvetti A.; Ferrannini E.; Monzani F.; Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab  2003,88(8),3731-3737","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.2174\/138161208786264142","volume":"14","author":"Iacoviello M.","year":"2008","unstructured":"Iacoviello M.; Guida P.; Guastamacchia E.; Triggiani V.; Forleo C.; Catanzaro R.; Cicala M.; Basile M.; Sorrentino S.; Favale S.; Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients. Curr Pharm Des  2008,14(26),2686-2092","journal-title":"Curr Pharm Des"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1097\/MD.0000000000001159","volume":"94","author":"Ning N.","year":"2015","unstructured":"Ning N.; Gao D.; Triggiani V.; Iacoviello M.; Mitchell J.E.; Ma R.; Zhang Y.; Kou H.; Prognostic role of hypothyroidism in heart failure. Medicine  2015,94(30),e1159","journal-title":"Medicine"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/187153012799278947","volume":"12","author":"Triggiani V.","year":"2012","unstructured":"Triggiani V.; Iacoviello M.; Monzani F.; Puzzovivo A.; Guida P.; Forleo C.; Matteo C.M.; Catanzaro R.; Tafaro E.; Licchelli B.; Angelo G.V.; Guastamacchia E.; Favale S.; Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: Role of amiodarone. Endocr Metab Immune Disord Drug Targets  2012,12(1),86-94","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1871530311313010005","volume":"13","author":"Triggiani V.","year":"2013","unstructured":"Triggiani V.; Iacoviello M.; Thyroid disorders in chronic heart failure: From prognostic set-up to therapeutic management. Endocr Metab Immune Disord Drug Targets  2013,13(1),22-37","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1871530316666151218151319","volume":"16","author":"Triggiani V.","year":"2016","unstructured":"Triggiani V.; Angelo Giagulli V.; De Pergola G.; Licchelli B.; Guastamacchia E.; Iacoviello M.; Mechanisms explaining the influence of subclinical hypothyroidism on the onset and progression of chronic heart failure. Endocr Metab Immune Disord Drug Targets  2016,16(1),2-7","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.2174\/1871530321666210430131510","volume":"21","author":"Terlizzese P.","year":"2021","unstructured":"Terlizzese P.; Albanese M.; Grande D.; Parisi G.; Gioia M.I.; Brunetti N.D.; Lisi F.; Lisco G.; Di Serio F.; Ciccone M.M.; Triggiani V.; Iacoviello M.; TSH variations in chronic heart failure outpatients: Clinical correlates and outcomes. Endocr Metab Immune Disord Drug Targets  2021,21(10),1935-1942","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/1871530319666191018134524","volume":"20","author":"Iacoviello M.","year":"2020","unstructured":"Iacoviello M.; Parisi G.; Gioia M.I.; Grande D.; Rizzo C.; Guida P.; Lisi F.; Giagulli V.A.; Licchelli B.; Di Serio F.; Guastamacchia E.; Triggiani V.; Thyroid disorders and prognosis in chronic heart failure: A long-term follow-up study. Endocr Metab Immune Disord Drug Targets  2020,20(3),437-445","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/5584_2017_132","volume":"1067","author":"Rizzo C.","year":"2017","unstructured":"Rizzo C.; Gioia M.I.; Parisi G.; Triggiani V.; Iacoviello M.; Dysthyroidism and chronic heart failure: Pathophysiological mechanisms and therapeutic approaches. Adv Exp Med Biol  2017,1067,239-253","journal-title":"Adv Exp Med Biol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s12020-021-02912-w","volume":"75","author":"Lisco G.","year":"2022","unstructured":"Lisco G.; Giagulli V.A.; Iovino M.; Zupo R.; Guastamacchia E.; De Pergola G.; Iacoviello M.; Triggiani V.; Endocrine system dysfunction and chronic heart failure: A clinical perspective. Endocrine  2022,75(2),360-376","journal-title":"Endocrine"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ijcard.2015.02.055","volume":"184","author":"Arcopinto M.","year":"2015","unstructured":"Arcopinto M.; Salzano A.; Bossone E.; Ferrara F.; Bobbio E.; Sirico D.; Vriz O.; De Vincentiis C.; Matarazzo M.; Saldamarco L.; Sacc\u00e0 F.; Napoli R.; Iacoviello M.; Triggiani V.; Isidori A.M.; Vigorito C.; Isgaard J.; Cittadini A.; Multiple hormone deficiencies in chronic heart failure. Int J Cardiol  2015,184,421-423","journal-title":"Int J Cardiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s11739-018-1844-8","volume":"13","author":"Bossone E.","year":"2018","unstructured":"Bossone E.; Arcopinto M.; Iacoviello M.; Triggiani V.; Cacciatore F.; Maiello C.; Limongelli G.; Masarone D.; Perticone F.; Sciacqua A.; Perrone-Filardi P.; Mancini A.; Volterrani M.; Vriz O.; Castello R.; Passantino A.; Campo M.; Modesti P.A.; De Giorgi A.; Monte I.; Puzzo A.; Ballotta A.; Caliendo L.; D\u2019Assante R.; Marra A.M.; Salzano A.; Suzuki T.; Cittadini A.; Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: Rationale, design, and demographic characteristics of the T.O.S.CA. Registry. Intern Emerg Med  2018,13(5),661-671","journal-title":"Intern Emerg Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/eurjpc\/zwab020","volume":"28","author":"Cittadini A.","year":"2021","unstructured":"Cittadini A.; Salzano A.; Iacoviello M.; Triggiani V.; Rengo G.; Cacciatore F.; Maiello C.; Limongelli G.; Masarone D.; Perticone F.; Cimellaro A.; Perrone Filardi P.; Paolillo S.; Mancini A.; Volterrani M.; Vriz O.; Castello R.; Passantino A.; Campo M.; Modesti P.A.; De Giorgi A.; Monte I.P.; Puzzo A.; Ballotta A.; D\u2019Assante R.; Arcopinto M.; Gargiulo P.; Sciacqua A.; Bruzzese D.; Colao A.; Napoli R.; Suzuki T.; Eagle K.A.; Ventura H.O.; Marra A.M.; Bossone E.; Investigators T.O.S.C.A.; Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry. Eur J Prev Cardiol  2021,28(15),1691-1700","journal-title":"Eur J Prev Cardiol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.eprac.2022.11.011","volume":"29","author":"Zhong J.","year":"2023","unstructured":"Zhong J.; Mu D.; Zou Y.; Li L.; Cheng X.; Qiu L.; High thyrotropin levels and risk of mortality in the elderly with subclinical hypothyroidism: A systematic review and meta-analysis. Endocr Pract  2023,29(3),206-213","journal-title":"Endocr Pract"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2174\/1871530319666191119112950","volume":"20","author":"Lisco G.","year":"2020","unstructured":"Lisco G.; De Tullio A.; Iacoviello M.; Triggiani V.; Congestive heart failure and thyroid dysfunction: The role of the low t3 syndrome and therapeutic aspects. Endocr Metab Immune Disord Drug Targets  2020,20(5),646-653","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00059-014-4123-0","volume":"40","author":"Marrakchi S.","year":"2015","unstructured":"Marrakchi S.; Kanoun F.; Idriss S.; Kammoun I.; Kachboura S.; Arrhythmia and thyroid dysfunction. Herz  2015,40(S2),101-109","journal-title":"Herz"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5937\/jomb0-39570","volume":"42","author":"Fu J.","year":"2023","unstructured":"Fu J.; Wang Y.; Liu Y.; Song Q.; Cao J.; Peichang W.; Reference intervals for thyroid hormones for the elderly population and their influence on the diagnosis of subclinical hypothyroidism. J Med Biochem  2023,42(2),258-264","journal-title":"J Med Biochem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1013641","DOI":"10.3389\/fendo.2022.1013641","volume":"13","author":"Triggiani V.","year":"2022","unstructured":"Triggiani V.; Cittadini A.; Lisco G.; Effect of levothyroxine replacement therapy in patients with subclinical hypothyroidism and chronic heart failure: A systematic review. Front Endocrinol  2022,13,1013641","journal-title":"Front Endocrinol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/187153012802002875","volume":"12","author":"Resta F.","year":"2012","unstructured":"Resta F.; Triggiani V.; Barile G.; Benigno M.; Suppressa P.; Giagulli V.A.; Guastamacchia E.; Sabb\u00e0 C.; Subclinical hypothyroidism and cognitive dysfunction in the elderly. Endocr Metab Immune Disord Drug Targets  2012,12(3),260-267","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1210\/jc.2012-3818","volume":"98","author":"Pasqualetti G.","year":"2013","unstructured":"Pasqualetti G.; Tognini S.; Polini A.; Caraccio N.; Monzani F.; Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? J Clin Endocrinol Metab  2013,98(6),2256-2266","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jamainternmed.2021.5078","volume":"181","author":"van Vliet N.A.","year":"2021","unstructured":"van Vliet N.A.; van Heemst D.; Almeida O.P.; \u00c5svold B.O.; Aubert C.E.; Bae J.B.; Barnes L.E.; Bauer D.C.; Blauw G.J.; Brayne C.; Cappola A.R.; Ceresini G.; Comijs H.C.; Dartigues J.F.; Degryse J.M.; Dullaart R.P.F.; van Eersel M.E.A.; den Elzen W.P.J.; Ferrucci L.; Fink H.A.; Flicker L.; Grabe H.J.; Han J.W.; Helmer C.; Huisman M.; Ikram M.A.; Imaizumi M.; de Jongh R.T.; Jukema J.W.; Kim K.W.; Kuller L.H.; Lopez O.L.; Mooijaart S.P.; Moon J.H.; Moutzouri E.; Nauck M.; Parle J.; Peeters R.P.; Samuels M.H.; Schmidt C.O.; Schminke U.; Slagboom P.E.; Stordal E.; Vaes B.; V\u00f6lzke H.; Westendorp R.G.J.; Yamada M.; Yeap B.B.; Rodondi N.; Gussekloo J.; Trompet S.; Association of thyroid dysfunction with cognitive function. JAMA Intern Med  2021,181(11),1440-1450","journal-title":"JAMA Intern Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s43162-020-00003-2","volume":"32","author":"Elbadawy A.M.","year":"2020","unstructured":"Elbadawy A.M.; Mansour A.E.; Abdelrassoul I.A.; Abdelmoneim R.O.; Relationship between thyroid dysfunction and dementia. Egypt J Intern Med  2020,32(1),9","journal-title":"Egypt J Intern Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.parkreldis.2020.04.001","volume":"74","author":"Chen S.F.","year":"2020","unstructured":"Chen S.F.; Yang Y.C.; Hsu C.Y.; Shen Y.C.; Risk of Parkinson\u2019s disease in patients with hypothyroidism: A nationwide population-based cohort study. Parkinsonism Relat Disord  2020,74,28-32","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/590648","volume":"2012","author":"Hage M.P.","year":"2012","unstructured":"Hage M.P.; Azar S.T.; The link between thyroid function and depression. J Thyroid Res  2012,2012,1-8","journal-title":"J Thyroid Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000356507","volume":"2","author":"Pearce S.H.S.","year":"2013","unstructured":"Pearce S.H.S.; Brabant G.; Duntas L.H.; Monzani F.; Peeters R.P.; Razvi S.; Wemeau J.L.; 2013 ETA guideline: Management of subclinical hypothyroidism. Eur Thyroid J  2013,2(4),215-228","journal-title":"Eur Thyroid J"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/thy.1991.1.241","volume":"1","author":"Hays M.T.","year":"1991","unstructured":"Hays M.T.; Localization of human thyroxine absorption. Thyroid  1991,1(3),241-248","journal-title":"Thyroid"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/1871530318666180125155348","volume":"18","author":"Guglielmi R.","year":"2018","unstructured":"Guglielmi R.; Grimaldi F.; Negro R.; Frasoldati A.; Misischi I.; Graziano F.; Cipri C.; Guastamacchia E.; Triggiani V.; Papini E.; Shift from levothyroxine tablets to liquid formulation at breakfast improves quality of life of hypothyroid patients. Endocr Metab Immune Disord Drug Targets  2018,18(3),235-240","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"441","DOI":"10.5603\/EP.a2020.0065","volume":"71","author":"Gietka-Czernel M.","year":"2020","unstructured":"Gietka-Czernel M.; Hubalewska-Dydejczyk A.; Kos-Kud\u0142a B.; Lewi\u0144ski A.; Rucha\u0142a M.; Syrenicz A.; Zgliczy\u0144ski W.; Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation \u2014 Tirosint SOL [Opinia ekspert\u00f3w dotycz\u0105ca stosowania p\u0142ynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynno\u015b\u0107 tarczycy]. Endokrynol Pol  2020,71(5),441-465","journal-title":"Endokrynol Pol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666230828110153","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220429\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666230828110153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T10:30:13Z","timestamp":1715941813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220429\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530323666230828110153","relation":{},"ISSN":["1871-5303"],"issn-type":[{"type":"print","value":"1871-5303"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}